Drug Shortage Report for CYSTO-CONRAY II
| Report ID | 198134 |
| Drug Identification Number | 00397466 |
| Brand name | CYSTO-CONRAY II |
| Common or Proper name | Iothalamate Meglumine Injection 17.2% w/v |
| Company Name | LIEBEL-FLARSHEIM COMPANY LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOTHALAMATE MEGLUMINE |
| Strength(s) | 172MG |
| Dosage form(s) | SOLUTION |
| Route of administration | URETHRAL URETHRAL |
| Packaging size | 250 mL |
| ATC code | V08AA |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-08-05 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-08-06 |
| Company comments | Current supply is on allocation with out of supply anticipated in early August 2023. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8800 DURANT RD. RALEIGH, NORTH CAROLINA UNITED STATES 27616 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-08-06 | English | Compare |
| v2 | 2023-07-11 | French | Compare |
| v1 | 2023-07-11 | English | Compare |
Showing 1 to 3 of 3